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Anumber of chronicmetabolic pathologies, including obesity, diabetes, cardiovascular disease, asthma, and
cancer, cluster together to present the greatest threat to human health. As research in this field has
advanced, it has become clear that unresolved metabolic inflammation, organelle dysfunction, and other
cellular and metabolic stresses underlie the development of these chronic metabolic diseases. However,
the relationship between these systems and pathologicalmechanisms is poorly understood. Herewe discuss
the role of cellular Ca2+ homeostasis as a critical mechanism integrating themyriad of cellular and subcellular
dysfunctional networks found in metabolic tissues such as liver and adipose tissue in the context of meta-
bolic disease, particularly in obesity and diabetes.Inappropriate consumption of nutrients and chronic metabolic
diseases are the hallmarks of this century, presenting the great-
est global public health problem and a major unmet need for
novel therapies. One way to consider such a high prevalence
of these diseases among modern humans is that they reflect
inherent limitations in the adaptive capacity of the organism to
offset chronic metabolic challenges. During normal feeding
cycles, the intake of calories in all forms (lipids, proteins, and car-
bohydrates) leads to acute fluctuations in the energy and nutrient
load, demanding an adaptive response from the metabolic net-
works that cells have developed to reestablish homeostasis.
Even massive quantities of caloric intake can be managed in
short periods of time, such as in the striking example of the Bur-
mese python, which is well adapted to a lifestyle characterized
by extremely large meals (ingestion of prey up to 1.6 times the
snake’s mass) spaced over long intervals (Riquelme et al.,
2011; Secor and Diamond, 1998). Chronic exposure to exces-
sive nutrients and energy, however, presents a continuous chal-
lenge for which there has not been an opportunity for the
selection and proper development of these adaptive pathways,
triggering local and systemic stress responses, such as meta-
flammation and organelle dysfunction, that ultimately lead to
the development of chronic and complex metabolic diseases
(Egger, 2012; Fu et al., 2012b; Gregor and Hotamisligil, 2011).
Several important mechanisms have been demonstrated to
contribute to the development of cellular stress responses and
systemic metaflammation. However, how these systems relate
to each other and are integrated is not well understood (Glass
and Olefsky, 2012; Gregor and Hotamisligil, 2011; Hotamisligil,
2006; Kahn et al., 2006; Lumeng and Saltiel, 2011; Qatanani
and Lazar, 2007; Shulman, 2000). Here we discuss a potential
role for cellular Ca2+ homeostasis as an important contributing
factor sustaining organelle dysfunction and the systemic integra-
tion of critical stress responses in metabolic organs such as the
liver and adipose tissue. The main premise of this discussion is
that cellular Ca2+ homeostasis also fails to maintain its adaptive
integrity in the face of structural and signaling defects introduced
by chronic metabolic challenges. For example, continuous sub-strate flow can drive synthetic pathways such as lipogenesis that
would impair endoplasmic reticulum (ER) membrane properties
and adaptive capacity through impaired Ca2+ fluxes and homeo-
stasis in the target cells, creating a feedforward pathological
cycle including the engagement of stress and metaflammatory
pathways and impaired hormone secretion and action. If such
a Ca2+-related framework is critical in the integrated pathological
sequences that characterize chronic metabolic diseases, then
it may be possible to exploit several elements for therapeutic
interventions.
Ca2+ is the most abundant ion in the body, primarily stored in
bones in the form of CaPO3 (hydroxyapatite). In bone, Ca
2+ plays
a structural role and also can be dissolved, serving as a source
of cations in the blood (Pozzan et al., 1994). Outside of the skel-
eton, Ca2+ is a ubiquitous and versatile signaling molecule con-
trolling a wide variety of cellular processes, including muscle
contraction, neuronal transmission, hormone secretion, organ-
elle communication, cellular motility, fertilization, and cell growth
(Berridge, 2012; Clapham, 2007; Pozzan et al., 1994). Given
these critical and diverse functions, cellular Ca2+ concentration
is tightly regulated, and dysfunction of cellular Ca2+ homeostasis
is associated with several pathological conditions as well as
aging (Guerrero-Hernandez and Verkhratsky, 2014; Luo and
Anderson, 2013; Toescu and Verkhratsky, 2007).
Alterations in Ca2+ homeostasis in the context of metabolic
stress, obesity, and diabetes strongly affect tissues, including
the heart and skeletal muscle, where Ca2+ plays an essential
role in muscle contraction, and the pancreas, where Ca2+ is
indispensable for insulin and glucagon secretion in response to
fluctuations in blood glucose. The role of intracellular Ca2+ ho-
meostasis and dysfunction in these tissues has been the focus
of intense research and is reviewed elsewhere (Carvajal et al.,
2014; Eizirik et al., 2008; Erickson, 2014; Eshima et al., 2014; Fer-
na´ndez-Velasco et al., 2014; Gilon et al., 2014; Guerrero-Her-
nandez and Verkhratsky, 2014; Pereira et al., 2014; Ramadan
et al., 2011), and, therefore, we will not cover this aspect of the
field in depth here. We will provide an overview of Ca2+ homeo-
stasis in key organelles, such as the ER and mitochondria, inCell Metabolism 22, September 1, 2015 ª2015 Elsevier Inc. 381
Figure 1. Ca2+ Homeostasis in the ER
(A) ER protein folding machinery. During glycoprotein biosynthesis, the translation of nascent polypeptides is followed by the translocation of the peptides
through the SEC61 pore. Sugar molecules are added to the polypeptides that are recognized by lectin chaperones such as calnexin (CNX) and calreticulin
(CRT), which function in complex with ERp57 and ERp72. Additional chaperone assistance is provided by the chaperones BiP (GRP78) and GRP94. CNX also
binds Ca2+ with high capacity, functioning as the main Ca2+ buffer in the ER lumen. Ca2+ depletion leads to the accumulation of misfolded proteins and the
activation of the UPR, mediated by three canonical ER luminal sensors (IRE1, PERK, and ATF6) that are inactive and bound to BiP in the absence of stress.
(B) Tool-kit of Ca2+ handling proteins. Ligand binding of GPCRs leads to the biosynthesis of intracellular messengers such as IP3, which diffuse into the cell and
bind to IP3R, stimulating Ca2+ release from the ER. Ca2+ channels activated by IP3 release Ca2+ from the ER to the cytosol. RyR also releases Ca2+ from the ER to
the cytosol. SERCA (Ca2+-ATPase) pumps Ca2+ from the cytosol to the ER lumen at the expense of ATP hydrolysis. STIM is an ER membrane protein that
possesses two EF hand domains. Under basal conditions, Ca2+ is bound to these domains, and the protein remains in itsmonomeric form. After Ca2+ release from
the ER, Ca2+ dissociates from the STIM proteins, leading to oligomerization and trafficking of STIM through the ER membrane toward the plasma membrane
contact sites. This localization allows STIM to couple with the plasma membrane Ca2+ channel Orai, and Ca2+ enters the cell from the extracellular space, a
process known as SOCE. SERCA colocalizes with the STIM/Orai complex and is thought to pump Ca2+ directly from the cytosol to the ER lumen.
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on recent research that leads us to propose that the disruption of
Ca2+ signaling can be an important mechanism in the myriad of
cellular and subcellular dysfunctional networks in the context
of obesity and type 2 diabetes, with potential implications for
other complex diseases of an immunometabolic nature.
Intracellular Ca2+ Dynamics in ER and Mitochondrial
Function
Ca2+ signaling occurs in a wide dynamic range, and its outcome
depends on the speed, amplitude, and oscillation of Ca2+ release
patterns in a temporally and spatially regulated manner (Dol-
metsch et al., 1998; Hajno´czky et al., 1995). For example, a
Ca2+ signal can be transducedwithinmilliseconds duringmuscle
contraction, or it can take minutes or hours, for example, in tran-
scriptional regulation and cell proliferation. Spatially, the rise in
cytosolic Ca2+ levels can be localized, as it is during neuronal
synapsis and cell-cell communication, or it can also diffuse
across the cell as a wave and trigger an effect at a location
distant from the origin of the stimulus (Dolmetsch et al., 1998;
Hajno´czky et al., 1995). Cytosolic Ca2+ levels are maintained at
low levels (10–100 nM) against a huge (20,000-fold) Ca2+ con-
centration gradient in intracellular stores and in the extracellular
milieu (Clapham, 2007). The regulation of cytosolic and organelle
Ca2+ levels is achieved by the orchestrated action of an exten-
sive signaling machinery that comprises proteins able to either382 Cell Metabolism 22, September 1, 2015 ª2015 Elsevier Inc.pump Ca2+ out from the cytosol to the extracellular space or
into intracellular stores and compartments such as the ER and
mitochondria (Pozzan et al., 1994). The complex structural na-
ture, dynamics, and trafficking of these transport proteins and
the interactions between subcellular organelles through special-
ized domains all require precise membrane properties and
integrity for proper homeostasis, which are challenged during
metabolic stress.
Ca2+ Homeostasis in the Endoplasmic Reticulum
The ER is a multifunctional organelle that serves as the most
important Ca2+ store in the cell. This organelle is able to accumu-
late Ca2+ at millimolar levels in both free and protein-buffered
forms (Mekahli et al., 2011; Pozzan et al., 1994; Prins andMicha-
lak, 2011). The Ca2+ stored in the ER lumen is essential for the
regulation of protein posttranslational processing, folding, and
export and can be rhythmically released to the cytosol, providing
sustained and precise Ca2+-mediated responses.
Ca2+ distribution within the ER is not homogeneous (Petersen
et al., 2001), and its regulation across the ER membrane is facil-
itated by three classes of well-studied proteins: Ca2+ release
channels (inositol-1,4,5-triphosphate [IP3] receptors [IP3Rs]
and ryanodine receptors [RyRs]), Ca2+ pumps (sarco-endo-
plasmic reticulum Ca2+-ATPases [SERCAs] that take up Ca2+
from the cytosol to the ER lumen), and Ca2+ binding proteins
(Clapham, 2007; Mekahli et al., 2011; Pozzan et al., 1994; Prins
and Michalak, 2011) (Figure 1; Table 1).
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enzymes occurs against its chemical gradient and requires en-
ergy released from ATP hydrolysis (de Meis and Vianna, 1979;
Toyoshima and Inesi, 2004). Ca2+ stored in the ER is then
released to the cytosol through the IP3R and RyRCa2+ channels.
The release of Ca2+ from the ER during the generation of cyto-
solic Ca2+ signals leads to the depletion of ER luminal Ca2+.
Two homologous ER proteins, STIM1 and STIM2, can sense
this decrease in Ca2+ through EF hand domains and respond
by activating the entry of Ca2+ from the extracellular environment
into the cell, a process known as capacitive or store-operated
calcium entry (SOCE). Ca2+ dissociation from the EF hand do-
mains of STIM proteins leads to a rapid oligomerization and
trafficking of STIM in the ERmembrane toward the plasmamem-
brane. At this site, STIM couples with the plasma membrane
channel Orai, allowingCa2+ to enter the cell from the extracellular
milieu. Upon the entrance of Ca2+ to the cytosol, SERCA pumps
Ca2+ into the ER to replenish the deficit (Carrasco and Meyer,
2011; Soboloff et al., 2012).
Inside the ER, high levels of Ca2+ are essential for protein
folding and processing, in part because of the allosteric regula-
tion of many intraluminal proteins. These include buffering pro-
teins such as calsequestrin and calreticulin and chaperones
such as GRP78 (BiP, immunoglobulin binding protein), GRP94
(endoplasmin), calnexin, and GRP170/ORP150. A third class
of Ca2+-regulated proteins includes the oxidoreductases PDI,
ERp57, ERp72, and ERO1L, which provide an electron transport
pathway from thiol residues tomolecular oxygen during disulfide
bond formation (Gorlach et al., 2006). ER Ca2+ depletion impairs
the function of all of these proteins and, if persistent, results in
the accumulation of unfolded proteins. This situation triggers
a well-known adaptive response, called the unfolded protein
response (UPR), with the goal of decreasing protein translation
while selectively increasing chaperone expression and in-
creasing protein degradation. When unsuccessful, this response
can also trigger cell death. ER dysfunction is a well-established
component of metabolic pathologies and homeostasis, and
the canonical UPR pathways aswell as their metabolic relevance
are reviewed in detail elsewhere and will not be covered here
(Hotamisligil, 2010b; Marciniak and Ron, 2006; Mori, 2000;
Zhao and Ackerman, 2006).
Ca2+ Homeostasis in Mitochondria
Ca2+ uptake in isolated mitochondria was directly measured for
the first time more than 50 years ago (Deluca and Engstrom,
1961), and it is now well accepted that Ca2+ uptake in mitochon-
dria is essential for their function and also contributes to the
regulation of cytosolic Ca2+ concentrations.
The main force driving mitochondrial Ca2+ uptake is the elec-
trochemical gradient formed across the mitochondrial inner
and outer membranes (Rizzuto et al., 1987). To get into the
mitochondrial matrix, Ca2+ first crosses the outer mitochon-
drial membrane (OMM), which is permeable to Ca2+ through
voltage-dependent anion channels (VDACs). VDACs act as gen-
eral diffusion pores for small hydrophilic molecules and connect
with IP3Rs in the ER through linkage with the chaperone GRP75
(Szabadkai et al., 2006). This structure allows Ca2+ transfer be-
tween the ER and the mitochondria, as will be described in
further detail below. The inner mitochondrial membrane (IMM)
is impermeable to ions, and the transport of Ca2+ occurs throughthe mitochondrial Ca2+ uniporter (MCU), a low-affinity (Kd of
20–30 mM under physiological conditions), low-conductance
channel that allows the rapid accumulation of Ca2+ depending
on the electrochemical gradient (Chaudhuri et al., 2013; Kirichok
et al., 2004). The MCU is regulated by various interacting pro-
teins forming a large complex in the IMM (Figure 2; Table 1).
Rapid Ca2+ uptake into mitochondria is counteracted by an
extrusion mechanism mediated by the mitochondrial antiporter
exchanging Na+/Ca2+ (in excitable tissues such as neurons
and skeletal muscle) or H+ (in the liver and other tissues) (Palty
et al., 2012).
Within the mitochondria, Ca2+ regulates intrinsic functions of
the organelle, such as the activity of the citric acid cycle and
NADH and ATP synthesis. Three matrix dehydrogenases are
activated by Ca2+: pyruvate dehydrogenase phosphatase, a-ke-
toglutarate dehydrogenase, and isocitrate dehydrogenase. Their
stimulation by Ca2+ increases NADH availability. The increased
level of NADH drives an increase in the flow of electrons through
the respiratory chain, enhancing ATP synthesis to meet the
needs of the cell. Therefore, mitochondrial Ca2+ flux is a critical
regulator of aerobic metabolism (Rizzuto et al., 2012). On the
other hand, excessive Ca2+ accumulation is associated with
mitochondrial dysfunction. For example, Ca2+ overload leads
to increased mitochondrial reactive oxygen species (ROS) pro-
duction by activating ROS-generating enzymes such as glycerol
phosphate and a-ketoglutarate dehydrogenase, by enhancing
nitric oxide generation and consequent respiratory inhibition,
and by stimulating the opening of the mitochondrial permeability
transition pore (PTP) (Kowaltowski et al., 2009; Peng and Jou,
2010). Opening of the PTP leads to a collapse of membrane
potential and mitochondrial swelling with consequent loss of
nucleotides and cytochrome c and is directly linked with
apoptotic cell death (Baines et al., 2005; Kowaltowski et al.,
2009). Recently, mitochondrial Ca2+ overload has also been
implicated in mitophagy, the selective degradation of damaged
mitochondria through autophagy (Rimessi et al., 2013). There-
fore, the precise regulation of mitochondrial Ca2+ levels is crucial
for themaintenance of homeostasis and the fine-tuned control of
mitochondrial Ca2+ uptake is a critical determinant of cellular
function and survival.
The recent identification of the proteins involved in regulating
mitochondrial Ca2+ uptake and efflux has led to a flurry of publi-
cations and renewed interest in this field, highlighting the gaps
that remain to be filled in terms of our understanding of mito-
chondrial Ca2+ flux in cellular function andmetabolism (reviewed
by Chaudhuri et al., 2013; De Stefani and Rizzuto, 2014; Foskett
and Philipson, 2015).
Ca2+ Homeostasis and ER-Mitochondria Interaction
Although the ER and mitochondria play distinct cellular roles,
these organelles are also functionally coupled and form physical
interactions at sites defined as mitochondria-associated ER
membranes (MAMs). The association between the ER and mito-
chondria was first described by Copeland and Dalton over
50 years ago in pseudo branch gland cells, and their function
was originally characterized biochemically (Copeland and
Dalton, 1959). Recently, advances in molecular biology and im-
aging technologies have allowed cell biologists to better under-
stand the specificity and dynamic nature of these contacts and
to unveil their physiological functions (reviewed in Giorgi et al.,Cell Metabolism 22, September 1, 2015 ª2015 Elsevier Inc. 383
Figure 2. Components of the MAMs and Ca2+ Homeostasis in the Mitochondria
(A) Electron microscopic images exemplifying the close contacts between the ER and mitochondria in mouse liver cells. Dense areas show the proteinaceous
bridges formed between the two membranes. The right panel shows a close-up of ER-mitochondrial membrane connection.
(B) The MAM connection is mediated by protein tethers such as mitofusin2 (MFN2) and stabilized by proteins such as PACS-2 bound to ER-resident CNX. The
MAMs are enriched in proteins that regulate Ca2+ transport from the ER to the mitochondria, such as IP3R, connected to the mitochondria anion transporter
(VDAC) by the chaperone GRP75. Through these structures, Ca2+ leaves the ER and enters the mitochondrial matrix via the MCU located in the IMM. The
MCU is regulated by a series of binding partners such as MICU1 and MICU2, MICUR1, and EMRE. MICU1 functions as a gatekeeper for MCU-mediated Ca2+
uptake. MICU2 seems to inhibit MCU function. EMRE is essential for the interaction between MCU and the MICU proteins and is indispensable for MCU-
mediated Ca2+ transport. The exit pathway for mitochondrial Ca2+ is mediated by the NCLX antiporter that exchanges Na+/Ca2+. MAMs are also enriched in
key enzymes of lipid biosynthesis to facilitate the conversion of PA to PE and PC, as described in the text.
(C) Within the mitochondria, Ca2+ regulates the activity of matrix and citric acid cycle enzymes such as pyruvate dehydrogenase phosphatase (PDP1), a-ke-
toglutarate dehydrogenase (aKGDH), and isocitrate dehydrogenase (IDH). This culminates in increased NADH production that feeds the respiratory chain to
produce ATP.
(D) Mitochondrial Ca2+ overload leads to increased mitochondrial ROS production and opening of the mitochondrial PTP. The opening of the PTP leads to a
collapse of membrane potential and mitochondrial swelling with consequent loss of nucleotides and cytochrome c (CytoC) and is directly linked with apoptotic
cell death. Apoptosis is regulated by the BCL2 class of proteins such as BID, BAX, and BAD. Under normal conditions, the proapoptotic protein BAX is in the
cytosol. However, under apoptotic conditions, this protein interacts with BAD or BID located in the OMM, stimulating the permeabilization of the OMM.
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the total mitochondrial surface and function as a lipid raft (Hay-
ashi and Su, 2003; Vance, 1990; Figure 2). MAM connections
are tight and strong, maintained in part by proteins such as phos-
phofurin acidic cluster-sorting protein 2 (PACS-2), which has
been shown to be necessary to stabilize MAM connections.
PACS-2 is enriched in MAMs through its direct interaction with
the ER protein calnexin (Myhill et al., 2008), and experimental
suppression of PACS-2 can reduce MAM stability (Simmen
et al., 2005). MAMs are also thought to be secured by protein
tethers such as mitofusin-2, the ablation of which leads to ER-384 Cell Metabolism 22, September 1, 2015 ª2015 Elsevier Inc.mitochondrion disconnection (de Brito and Scorrano, 2008).
Interestingly, a recent report calls this concept into question by
demonstrating that deletion of mitofusin-2 unexpectedly and,
in contrast to the predictions, led to increased mitochondria-
ER interactions (Filadi et al., 2015). Additional studies will be
required to fully understand the details of the structural compo-
nents of these important organelle connections and their physi-
ological and pathological regulation.
MAMs are also enriched in proteins that regulate Ca2+ trans-
port from the ER to the mitochondria, such as IP3R, which ap-
pears to be connected to VDACs on the mitochondrial side by
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decreases MAM coupling and Ca2+ uptake into mitochondria
(Szabadkai et al., 2006). Furthermore, the presence of MAMs al-
lows the formation of microdomains of high Ca2+ concentrations
(10 mM) that exceed those measured in the cytosol under
healthy conditions. The existence of this structure explains
how low-affinity MCU is able to take up Ca2+ under physiological
conditions, solving what has been a major puzzle in the field
(Csorda´s et al., 1999; Rizzuto et al., 1992, 1998; Szalai et al.,
2000).
In recent years, the recognized repertoire of proteins that are
enriched at MAMs has grown and now includes the sigma 1 re-
ceptor (Hayashi and Su, 2007), a chaperone that regulates
IP3R activity; PKR-like endoplasmic reticulum-localized kinase
(PERK), a key component of canonical UPR (Verfaillie et al.,
2012); mTOR, a critical nutrient-sensing molecule; and AKT, a
key signaling molecule for hormones, including insulin (Betz
et al., 2013), among many others. In addition, key enzymes of
lipid biosynthesis such as PEMT2 (Cui et al., 1993), DGAT2
(Stone et al., 2009), and phosphatidyl serine synthase (PSS)
(Vance, 1990) are all present in high concentrations at MAMs,
indicating a role for this structure in lipid biosynthesis and traf-
ficking (Figure 2). Indeed, phosphatidylserine (PS) is produced
in the ER but needs to be transferred to the mitochondria to be
converted into phosphatidylethanolamine (PE). PE is then trans-
located back to the ER to be converted into phosphatidylcholine
(PC). Therefore, the MAM is a strategic location for the lipid syn-
thesis machinery, facilitating lipid trafficking.
In addition, MAMs seem to be important for autophagosome
formation. It has been reported that, upon suppression of mito-
fusin-2 and PACS-2, ER-mitochondria contacts are disrupted
and there is a decrease in autophagosome biogenesis (Hama-
saki et al., 2013). Another function of the MAM is to regulate
mitochondrial dynamics. Taking advantage of high-resolution
electron microscopy (EM) tomography and live confocal fluores-
cence microscopy, the Voeltz group has shown that the ER
marks the sites for mitochondrial fission and is involved in the
recruitment of proteins involved in mitochondrial division, such
as DRP1 (Friedman et al., 2011). The impact of this structure
on physiology and pathophysiology has been a topic of intense
research in recent years, and these findings suggest that, in
addition to modulating ER-mitochondrial Ca2+ homeostasis,
MAMs act as a signaling platform for the dynamic modulation
of multiple metabolic pathways (Figure 2). Taken together, it is
clear that many components of MAMs are linked to key meta-
bolic pathways.
Cytosolic Ca2+ Signaling
Cytosolic Ca2+ signaling is initiated by a stimulus that generates
a rise in intracellular Ca2+, which, in turn, modulates downstream
signaling pathways. In non-excitable cells, this cascade is most
commonly initiated by a hormone or other agonist binding to a
G protein-coupled receptor (GPCR) and the activation of canon-
ical signaling pathways. For example, glucagon (through the
glucagon receptor) and catecholamines (through the b-adren-
ergic receptors) activate the Gas protein, leading to stimulation
of adenylate cyclase activity and the production of cyclic AMP
(cAMP). These signals converge on protein kinase A (PKA),
which is able to phosphorylate and activate the IP3R, leadingto Ca2+ release from the ER (Bugrim, 1999). Alternatively, cate-
cholamine signaling through the a-adrenergic receptor activates
phospholipase C (PLC), which catalyzes the hydrolysis of phos-
phatidylinositol 4,5 bisphosphate (PIP2) to produce the intracel-
lular messengers IP3 and diacylglycerol (DAG) (Foskett et al.,
2007). IP3 diffuses into the cell and binds to IP3R, stimulating
Ca2+ release from the ER. DAG stimulates PKC, which regulates
an array of signaling pathways, including modulations of Ca2+
signaling (Clapham, 2007).
These signal-induced rises in cytosolic Ca2+ are transient,
follow an oscillatory pattern, and can be sensed by different pro-
teins. A central Ca2+-responsive protein is calmodulin (CaM), a
protein that undergoes conformational change following Ca2+
binding to its four EF hand domains (Zhang et al., 1995). CaM
binds to the regulatory regions of CaM-dependent kinases
(CaMKs) to relieve autoinhibition and allow the phosphorylation
of exogenous substrates. Among other substrates, CaMKs
havebeenassociatedwith direct phosphorylation of several tran-
scription factors critical for metabolism, inflammation, and other
related cellular processes, including FOXO (Ozcan et al., 2012),
CREB (Sheng et al., 1991), and CBP (Impey et al., 2002), with
the nuclear translocation of nuclear factor kB (NF-kB) (Ishiguro
et al., 2006) and activation of JNK (Timmins et al., 2009).
Another important Ca2+-dependent signaling molecule is Cal-
cineurin, also known as protein phosphatase-3, a serine/threo-
nine phosphatase that is activated by sustained high Ca2+ levels.
Calcineurin transduces cytosolic Ca2+ signals to the nucleus,
regulating the activity of at least three important transcription
pathways involving nuclear factor of activated T cells (NFAT)
(Choi et al., 1994), CREB-regulated transcription coactivator 2
(CRTC2) (Screaton et al., 2004), and myocyte enhancer factor-2
(MEF-2) (Mao and Wiedmann, 1999) and, therefore, controls
responses important in the immune, nervous, metabolic, and
cardiovascular systems (Figure 3).
Alterations in Ca2+ Homeostasis CauseOrganelle Stress
and Metabolic Disease
In this section, we will primarily focus on studies in the liver and
the emerging work applicable to adipose tissue and macro-
phages to illustrate the role of Ca2+ homeostasis in organelle
stress andmetabolic deterioration in obesity and diabetes. How-
ever, these concepts are applicable to anymetabolic or immuno-
logical target cell in influencing systemicmetabolic homeostasis.
Liver Metabolism, Function, and Ca2+ Homeostasis
The liver represents a major metabolic organ in its ability to
control gluconeogenesis, glycogen storage, lipogenesis, and
cholesterol and bile acid metabolism. During fasting, the liver
initially uses glycogen to mobilize glucose, and, when glycogen
is depleted, de novo synthesis of glucose fromnon-carbohydrate
precursors becomes themain determinant of the body’s ability to
maintain normoglycemia. The liver is also amajor site for de novo
synthesis of fatty acids and triacylglycerol and lipid excretion.
Fluctuations in cytosolic and organelle Ca2+ following
glucagon or epinephrine stimulation play a major role in the he-
patic control of glucose production; bile fluid movement and
excretion; fatty acid, amino acid, and xenobiotic metabolism;
protein synthesis and secretion; and cell cycle and cell prolifera-
tion, among other functions (Amaya and Nathanson, 2013; Bol-
len et al., 1987; Nathanson et al., 1992). The regulation of glucoseCell Metabolism 22, September 1, 2015 ª2015 Elsevier Inc. 385
Figure 3. Intracellular Ca2+ Signaling
GPCR activation by hormones can induce Ca2+ release by activating PLC,
leading to the hydrolysis of PIP2 to produce the intracellular messengers IP3
and DAG. IP3 diffuses into the cell and binds to IP3R, stimulating Ca2+ release
from the ER. Alternatively, GPCR activation leads to the production of cAMP,
which activates PKA, enabling it to phosphorylate IP3R and induce its activity.
In the cytosol, the two main Ca2+ sensors involved in signal transduction are
CaMK and calcineurin (CnA). CaMKs have been shown to directly phosphor-
ylate many targets, including the inflammatory proteins JNK and p38 and
transcription factors including FOXO and CREB. CnA is activated by sustained
high Ca2+ levels and regulates the activity of at least three important tran-
scription pathways involving NFAT and CRTC2.
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modulate the activity of key enzymes in the gluconeogenesis
pathway, such as pyruvate carboxylase, an enzyme that medi-
ates the synthesis of oxaloacetate from pyruvate, and phospho-
enolpyruvate carboxykinase, which converts oxaloacetate into
phosphoenol-pyruvate. Also, a rise in cytosolic Ca2+ levels leads
to the activation of the CaMKinase-FOXO pathway, which regu-
lates the expression of key gluconeogenesis genes (discussed in
more detail below). In addition to gluconeogenesis, Ca2+ regu-
lates glycogenolysis through the stimulation of the phosphory-
lase kinase and activation of glycogen phosphorylase, the
enzyme responsible for the catalysis of glucagon to glucose-
1-phosphate (Amaya and Nathanson, 2013; Exton, 1987).
Opposing the effects of glucagon and epinephrine is insulin,
the primary hormone stimulating glucose storage. Insulin influ-
ences cytosolic Ca2+ levels through the stimulation of AKT. It
has been shown that AKT is able to directly phosphorylate the
IP3R, inhibiting its function, attenuating cytosolic Ca2+ signaling,
and leading to increased ER Ca2+ concentrations. IP3R phos-
phorylation by AKT also has a strong antiapoptotic effect
(Khan et al., 2006; Marchi et al., 2012).
In the setting of obesity, the reduction in insulin sensitivity and
the continuous breakdown of lipids in adipose tissue and the386 Cell Metabolism 22, September 1, 2015 ª2015 Elsevier Inc.associated hormonal signals lead to overactivation of gluconeo-
genesis, contributing to hyperglycemia. Reduction in insulin
sensitivity also contributes to decreased fatty acid oxidation
and increased de novo lipid synthesis in the liver (Fu et al.,
2012b). Dysfunction of cellular organelles, including the ER and
mitochondria, are key mechanisms in the development of
abnormal insulin action and metabolic alterations in the liver
(Fu et al., 2012b; Mantena et al., 2008; Ozcan et al., 2004), and
emerging evidence suggests that disruption of Ca2+ homeosta-
sis in these organelles plays a central role.
While searching for the mechanisms underlying the develop-
ment of ER dysfunction and stress in metabolic disease, our
group identified obesity-induced dysfunctional ER Ca2+ trans-
port as an important cause of ER stress in the liver (Fu et al.,
2011). Excessive energy intake in obesity stimulates de novo
lipogenesis in the liver, leading to the accumulation of lipid drop-
lets and also to an imbalance in the synthesis of PC and PE, the
main phospholipids comprising the organelle membranes. An
increased PC/PE ratio of the ER membrane leads to altered
membrane fluidity, which reduces SERCA2b function, resulting
in decreased Ca2+ accumulation in the ER lumen and impaired
protein folding capacity (Fu et al., 2011). Similarly, two indepen-
dent groups have shown recently that the incorporation of satu-
rated fatty acids into the ER also reduces membrane fluidity and
SERCA function, decreasing luminal ER Ca2+ (Egnatchik et al.,
2014; Zhang et al., 2014b). It has also been shown that modula-
tion of LXRs regulates ER function through changes in mem-
brane phospholipid composition and lipogenic and inflammatory
responses (Rong et al., 2013). The importance of this mechanism
for the development of fatty liver and diabetes is evidenced by
the fact that overexpression of SERCA improves ER folding ca-
pacity and results in better glycemic control in obese leptin-defi-
cient mice (Fu et al., 2011; Park et al., 2010).
Based on high-throughput functional ER screening systems,
our group recently identified a new compound able to enhance
ER function and increase SERCA2b expression, resulting in
increased ER Ca2+ accumulation. Interestingly, this compound
shows strong anti-diabetic activities in mouse models (Fu
et al., 2015). Similarly, rosiglitazone, an insulin-sensitizing agent
in clinical use, has also been shown to induce SERCA expression
(Shah et al., 2005). In a genome-wide association study (GWAS)
meta-analysis, a SNP at the SERCA1 (ATP2A1) gene locus
was found to be associated with BMI (Locke et al., 2015), and
SNPs in the SERCA3 locus have been linked independently
to diabetes susceptibility (Varadi et al., 1999). Taken together,
these studies strongly support an important role for SERCA
function in metabolic homeostasis and suggest that targeting
SERCA may be a promising potential therapeutic avenue.
Indeed, small-molecule SERCA activators have been identified
(Cornea et al., 2013; Khan et al., 2009), but their potential effects
on metabolic disease have not yet been tested.
Alterations in Ca2+ flux also contribute to hepatic mitochon-
drial dysfunction in obesity. We showed recently that, in the
context of overnutrition and obesity, the total ERmembrane con-
tent in liver cells is diminished and reorganized, with significantly
increased ER-mitochondrial contact (MAMs) (Arruda et al.,
2014). The ER structure comprises two major morphologies
that include the nuclear envelope (NE) and the peripheral ER
that is subdivided in cisternae (sheets) and a tubular network
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ribosomes and are preferentially involved in protein synthesis.
Because a generalized decrease in protein synthesis is evident
in liver tissue in obesity (Fu et al., 2012a), it is likely that the
reduced ER content in hepatocytes seen in this condition (Arruda
et al., 2014) is primarily related to the cisternae. It will be inter-
esting to carefully characterize and quantitate the relative alter-
ations in different ER domains in the future.
In addition to a greater degree of ER-mitochondrial connectiv-
ity, the expression of the Ca2+ channel IP3R and tethering pro-
teins such as PACS-2 were increased significantly in the
MAMs isolated from liver cells in two different models of obesity.
This resulted in increased Ca2+ transfer from the ER tomitochon-
dria, leading to enhanced oxidative stress and compromised
oxidative phosphorylation. Remarkably, experimental suppres-
sion of IP3R1 or PACS-2 improved mitochondrial function and
resulted in significantly improved glucose tolerance in obese
mice (Arruda et al., 2014).
Increased ER-mitochondria interaction and Ca2+ transport
have also been shown under conditions of ER stress, such as
upon tunicamycin treatment, both in vivo (Arruda et al., 2014)
and in vitro (Bravo et al., 2011). Treatment of primary hepato-
cytes and immortalized H4IIEC3 hepatic cells with palmitate
decreased ER Ca2+ levels, elevated mitochondrial Ca2+ content,
reduced the mitochondrial membrane potential, and elevated
ROS. Importantly, treatment of these cells with the Ca2+
chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N’,N’-tetra-acetic
acid (BAPTA) abrogated the lipotoxic effects of palmitate (Egnat-
chik et al., 2014). It has also been shown that ERO1a, an oxido-
reductase involved in protein folding, is increased during ER
stress and can bind to IP3R1, activating Ca2+ release from the
ER and directly modulating mitochondrial Ca2+ levels (Anelli
et al., 2012). Furthermore, it has been shown recently that, in
the postprandial state (5 hr after feeding), the area of mitochon-
dria covered with ER doubles, and this is correlated with a 20%
decrease in mitochondrial oxidative capacity (Sood et al., 2014).
Taken together, these findings suggest that Ca2+ is a critical link
between ER and mitochondrial stress during nutrient fluctua-
tions and overload. Another group recently reported that MAM
content might be decreased in the liver of obese mice using
an indirect protein interaction-based system to evaluate MAM
function (Tubbs et al., 2014). Because ER and mitochondrial
abundance and interaction are regulated by metabolic exposure
and may differ depending on the stage of pathology, more
research will be required to understand the dynamic regulation
and modulation of these connections during metabolic disease
and their contribution to pathogenesis.
The role of Ca2+ flux through the IP3R in human metabolic dis-
ease has been suggested by a recent GWAS meta-analysis that
identified a SNP in the IP3R2 locus associated with alterations in
the waist-to-hip ratio adjusted for BMI (Shungin et al., 2015). In
addition, a role in hepatic metabolic dysfunction is supported
by two other important studies. First, work from the Montminy
laboratory (Wang et al., 2012) demonstrated that protein expres-
sion as well as the phosphorylation status of IP3R are increased
in a genetic model of obesity (db/db mice), resulting in higher
cytosolic Ca2+. Upon fasting, high levels of glucagon signaling
lead to increased cAMP and activation of PKA, which, in turn,
lead to phosphorylation and activation of the IP3R (Wang et al.,2012). Higher cytosolic Ca2+ culminates in the activation of
calcineurin, which promotes the CRTC2-mediated induction of
the FOXO1 transcriptional partner PGC1a to regulate gluconeo-
genesis, an important contributor to hyperglycemia in obesity.
Furthermore, suppression of IP3R1 in the liver enhances glucose
metabolism in obese mice (Wang et al., 2012).
Second, increased hepatic glucose production mediated by
the rise in cytosolic Ca2+ also seems to involve the Ca2+-sensing
enzymeCaMKII. The Tabas group (Ozcan et al., 2012) has shown
that, under fasting conditions, glucagon stimulates Ca2+ release
from the ER, which, in turn, leads to the activation of CaMKII.
CaMKII phosphorylates p38 and FOXO, leading to FOXO trans-
location to the nucleus and regulation of gluconeogenic genes. In
agreement with the finding of higher cytosolic Ca2+ in obesity,
CaMKII is hyperphosphorylated in hepatocytes of obese mice,
which contributes to JNK activation, inflammatory signaling,
and excessive glucose production (Ozcan et al., 2012). JNK
has been established previously as a key inflammatory kinase
causing impaired metabolic homeostasis in obesity (Hirosumi
et al., 2002; Manning and Davis, 2003; Vallerie and Hotamisligil,
2010), and activation of this pathway is reverted by blocking
IP3R1 both pharmacologically and genetically (Ozcan et al.,
2012). The CaMKII-p38a pathway also negatively impacts insulin
signaling by modulating PERK, a component of the UPR. As a
consequence, levels of ATF4, a PERK-regulated transcription
factor target, increase, inducing the expression of TRB3, which
directly inhibits insulin-mediated AKT phosphorylation. Inhibition
of the CaMKII-p38a pathway in hepatocytes makes the cells
resistant to UPR activation, and, in obese mice, genetic or phar-
macological inhibition of CaMKII results in a marked improve-
ment in metabolism, including the lowering of blood glucose
and insulin (Ozcan et al., 2013). In addition, CaMKII-deficient
obese mice have higher nuclear activating transcription factor
6 (ATF6) levels, which seems to have beneficial effects on
obesity and type 2 diabetes. It has been reported that ATF6
suppresses hepatic glucose production through disruption of
the CREB-CRTC2 interaction, a functionality that is diminished
in obesity in the liver (Wang et al., 2009) and pancreas (Engin
et al., 2014). Taken together, these findings directly link defective
Ca2+ homeostasis with ER stress, inflammatory signaling, and
deregulation of gluconeogenesis. In line with this evidence,
mice deficient for CaMKK2, an enzyme that activates and
phosphorylates CaMKs, are protected from diet-induced
obesity, hyperglycemia, and glucose intolerance, and deletion
of this enzyme specifically in the liver improves glucose toler-
ance (Anderson et al., 2012).
Increased cytosolic Ca2+ in the liver in the context of obesity
also seems to have an implication for the control of autophagy,
the main pathway through which organelles and single proteins
are recycled. It has been shown that, in late-stage obesity, auto-
phagic flux is decreased in the liver, and the expression levels of
the autophagy machinery proteins, such as ATG7, are markedly
suppressed (Yang et al., 2010). Importantly, this seems to be
connected with the overexpression of calpain, a Ca2+-depen-
dent protease that cleaves ATG7. Inhibition of calpain activity
in vivo by two independent calpain inhibitors resulted in an
enhanced ATG7 protein expression level and increased auto-
phagy (Yang et al., 2010). More recently, it has been shown
that lipotoxicity-induced elevation of cytosolic Ca2+ leads toCell Metabolism 22, September 1, 2015 ª2015 Elsevier Inc. 387
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somes, thereby attenuating the autophagic flux (Park and Lee,
2014). As a result, there is an accumulation of undegraded
autophagic substrates, such as ubiquitinated proteins and lipid
droplets. Importantly, treating obese animals with a Ca2+ chan-
nel blocker, verapamil, improves ER stress, general autophagic
flux, and glucose metabolism in obese animals (Park et al.,
2014). These results support a model where ER-mitochondria
interactions and Ca2+ fluxes may play an important role in the
regulation of autophagy, especially in the context of metabolic
disease (Figure 4A).
Adipose Tissue Function and Ca2+ Homeostasis
Adipose tissue is a critical regulator of energy metabolism
because it is able to store energy as lipids in triglycerides (TGs)
under circumstances where excess nutrients are available and
to hydrolyze TG, releasing fatty acids in the setting of insufficient
caloric intake. Adipose tissue also supports lactational meta-
bolism, and this function requires robust ER function (Gregor
et al., 2013). In the setting of obesity or chronic nutrient excess,
however, perturbations in adipose lipid metabolism occur in
response to the integration of various mechanisms, such as lipid
accumulation, inflammation, hypoxia, and oxidative stress, with
pathogenic consequences (Gregor and Hotamisligil, 2007).
Organelle stress such as increased mitochondrial lipid catabo-
lism, production of ROS, and UPR activation are key mecha-
nisms strongly contributing to adipose tissue inflammation,
including JNK activation, decline in metabolic function,
decreased survival, and the efflux of free fatty acids and other
mediators from adipocytes into the circulation (Cao et al.,
2008; Eissing et al., 2013; Gregor and Hotamisligil, 2007; Guil-
herme et al., 2008; Herman et al., 2012; Kershaw and Flier,
2004; Ozcan et al., 2004; Rajala and Scherer, 2003; Sun et al.,
2011). However, adipocytes present unique challenges to study
these processes, and, in general, there are important gaps in
studies exploring the ER or mitochondrial structure and function
in adipocytes.
In mammals, investigation of the role of Ca2+ homeostasis in
adipose tissue biology and pathophysiology is a new area of ac-
tivity. However, the accumulating evidence so far suggests that
Ca2+ imbalance may have important consequences for adipo-
cyte function. For example, a rise in cytosolic Ca2+ has been
shown to promote triglyceride accumulation and lipid storage
by controlling de novo lipogenesis through the regulation of
FAS expression (Jones et al., 1996; Zemel et al., 1995, 2000). It
is important to note that an acute rise in cytosolic Ca2+ can trans-
duce a lipolytic signal, whereas sustained high levels of Ca2+
inhibit lipolysis (Zemel et al., 2000). Modulation of cytosolic
Ca2+ has also been shown to regulate adipogenesis. Increasing
cytosolic Ca2+ by either inhibiting Ca2+-ATPase or stimulating
Ca2+ influx inhibits the early stages of murine adipocyte differen-
tiation in mouse models and human cell lines (Shi et al., 2000).
Furthermore, increasing cytosolic Ca2+ induces NFAT transcrip-
tion factors, which, in addition to promoting the production of in-
flammatory cytokines and other immune mediators, also play a
role in adipocyte differentiation and function by interacting with
C/EBP (Ho et al., 1998). It is likely that other transcriptional and
hormonal programs are also responsive to changes in Ca2+
fluxes and impact adipocyte differentiation, function, and sur-388 Cell Metabolism 22, September 1, 2015 ª2015 Elsevier Inc.vival. For example, increasing Ca2+ levels in adipocytes also in-
duces the secretion of hormones and cytokines such as aP2/
FABP4 (Ertunc et al., 2015; Fu et al., 2012b; Schlottmann
et al., 2014), and Ca2+ also seems to regulate the thermogenic
capacity of brown adipocytes (Leaver and Pappone, 2002;
Figure 4B).
Given these findings, it follows that alterations in Ca2+
signaling may play a role in adipose tissue dysfunction in meta-
bolic disease. For example, within hypertrophic adipocytes it has
been demonstrated that there is a deposition of Ca2+ surround-
ing the lipid droplets, possibly indicating increased cytosolic
Ca2+ in this condition (Giordano et al., 2013). Also, adipocytes
isolated from obese elderly humans display elevated cytosolic
Ca2+ levels (Byyny et al., 1992). In agreement with the finding
that obese adipocytes contain elevated cytosolic Ca2+, it has
been shown that NFAT transcription factor isoforms 2 (NFATc2)
and 4 (NFATc4) are induced in obesity and also during adipogen-
esis (Yang et al., 2006). Interestingly, mice deficient for both
NFATc2 and NFATc4 have decreased production of resistin in
adipose tissue and are insulin-sensitive and resistant to diet-
induced obesity (Yang et al., 2006). In obesity, both in experi-
mental models and in humans, there is significantly increased
JNK activity in adipose tissue, which has significant metabolic
consequences (Boden et al., 2008; Gregor et al., 2009; Tobar
et al., 2011; Tsukumo et al., 2007). Because this pathway is acti-
vated by CaMK in the liver, a similar regulatory link can also be
envisioned for adipose tissue supporting a role for Ca2+ fluxes
in the activation of inflammatory and stress signaling pathways.
Another piece of evidence of the connection between Ca2+
signaling and adipose tissue dysfunction has been reported
recently during the search for small molecules that stimulate
mitochondrial function and proliferation based on PGC1a activa-
tion. Using this approach, a plasma membrane Ca2+ channel,
transient receptor potential cation channel subfamily V member
4 (TRPV4), has been identified as a negative regulator of PGC1a
and a positive regulator of inflammatory genes. TRPV4 is highly
expressed in adipose tissue, and deletion or pharmacological in-
hibition in vivo leads to the activation of energy expenditure, acti-
vation of brown fat function, and decreased inflammation and
protects mice from diet-induced obesity and insulin resistance
(Ye et al., 2012). Although not measured directly, this effect
may also involve fluctuations in Ca2+ import to the cell.
Additional compelling evidence implicatingdysfunction inCa2+
metabolism and its implication to adipose metabolism comes
from studies performed in the model organism Drosophila mela-
nogaster. InDrosophila, systemicmetabolism is governed largely
by the fat body, an important immunometabolic organ that may
be considered the equivalent of the mammalian liver, adipose
tissue, and hematopoietic and immune systems (Hotamisligil,
2006). Therefore, the fly’s fat body serves a central role in sensing
energy and nutrient availability and coordinating the appropriate
metabolic, immune, and survival responses. Thus, mechanisms
studied thereinmay serve asmodels for evolutionarily conserved
pathways in multiple mammalian tissues (Tong et al., 2000). In
Drosophila, it has been shown recently that STIMacts as a poten-
tial regulator of adiposity.Genetic downregulation ofSTIM1 leads
to decreased intracellular Ca2+,which correlateswith an increase
in body fat accumulation in the flies. The mechanisms through
which STIM deficiency directly regulates adipose tissue content
Figure 4. Dysfunction of Ca2+ Homeostasis in Metabolic Disease
(A) In the livers of obese humans and animal models, the UPR is activated, and the phosphorylation of IRE1 (inositol required 1), PERK, and eIF2a are increased
(green arrows). However, the levels of sXBP1 and ATF6 activity are decreased (red arrows) in obesity in the liver (similar to b cells). Because of changes in ER
membrane composition (an increased ratio of PC/PE), the transport of Ca2+ from the cytosol to the ER lumen by SERCA is impaired, leading to decreased Ca2+
levels in the ER. Also, in the livers of obese animals, IP3R1 expression and activity are increased, which contributes both to decreased levels of ER Ca2+ and
increased cytosolic and mitochondrial Ca2+. In the mitochondria, Ca2+ overload correlates with increased oxidative stress (ROS) and decreased oxidative
function. Increased cytosolic Ca2+ also affects several cellular pathways such as autophagosome accumulation and activates proteases such as calpain that
cleave and degrade ATG7. Both phenomena culminate in decreased autophagy, as seen in liver in obesity. Increased cytosolic Ca2+ also activates CnA, leading
to dephosphorylation of CRTC2 and its nuclear translocation, and activates CaMK to phosphorylate FOXO with a direct impact on gluconeogenesis. CaMK also
phosphorylates p38 and JNK, leading to increased inflammation.
(BandC) Inboth adipocytes (B) andmacrophages (C) of obeseanimalmodels, theUPR isactivated, and thephosphorylationof IRE1,PERK, andeIF2a is increased.
(B) In hypertrophic adipocytes, there are increaseddeposition of Ca2+ surrounding the lipid droplets and increased cytosolic Ca2+ levels. NFAT transcription factor
isoforms2and4are induced in obese adipose tissue, driving the expression of inflammatory genes. TRPV4 is aCa2+-permeable ionchannel thatwas first identified
as an osmolality sensor. In adipocytes, it acts as a negative regulator of PGC1a and apositive regulator of inflammatory genes andproteins and JNKactivity. These
effects are related to the activation of ERK1/2.
(C) Macrophages derived from obese animals show increased IP3R1 and ERO1a activity, which leads to higher Ca2+ release from the ER to the cytosol. In
addition, reduced levels of SERCA2b mRNA and protein expression are observed under these conditions. Rises in cytosolic Ca2+ and mitochondrial oxidative
stress have been shown to engage the NLRP3 inflammasome pathway. In addition, the alterations in macrophage activity in obesity have been shown to activate
CaMKK, the deletion of which leads to impaired cytokine secretion and phagocytosis and induces morphological changes.
Cell Metabolism 22, September 1, 2015 ª2015 Elsevier Inc. 389
Cell Metabolism
Review
Cell Metabolism
Revieware not known but seem to involve a fat body-brain signaling axis
(Baumbach et al., 2014). In addition, Drosophila bearing muta-
tions in IP3R exhibit obesity (Subramanian et al., 2013), indicating
that changes in Ca2+ homeostasis directly impact fat deposition
in this organism.
Alterations in SERCA function and ER Ca2+ uptake also seem
to connect Ca2+ homeostasis with adiposity in Drosophila
because lipodystrophy mediated by disruption of Seipin, a pro-
tein involved in adipocyte differentiation and lipid droplet forma-
tion, can be explained by decreased ER Ca2+ transport through
SERCA. The expression of mutant seipin inDrosophila fat bodies
results in defective SERCA activity, lower ER content, and
elevated cytosolic Ca2+ levels. This coincides with decreased
fat storage and decreased lipogenesis (Bi et al., 2014). In the
same direction, it has been shown that genetic suppression of
IP3R and RyR in Drosophila leads to increased fat accumulation,
demonstrating that proper Ca2+ regulation is essential for fat tis-
sue storage in the fly (Bi et al., 2014). Although the implications
for higher organisms remain to be explored, the conservation
of many critical molecules and pathways suggests that future
work in this or other model organisms may be invaluable in un-
raveling the role of Ca2+ homeostasis in metabolism and pave
the way for exploring the functional consequences and mecha-
nisms in other systems.
Inflammatory Cells
As described above, the chronic metabolic diseases under
consideration here are linked to metaflammation, and, as such,
immune cell function and phenotype make critical contributions
to disease pathogenesis through integrated networks withmeta-
bolic and stromal cellular components (Glass andOlefsky, 2012).
Although many stromal and immune effector cells interact to
generate and sustain metaflammation, macrophages are the
most intensely studied, and their infiltration of metabolic tissues
such as adipose tissue and pancreatic islets is a hallmark of
obesity (Ehses et al., 2007; Stefanovic-Racic et al., 2012; Weis-
berg et al., 2003; Xu et al., 2003). Metabolic signals and stimuli
resulting from excess nutrient intake and metabolic stress drive
adipose tissue macrophages toward a pro-inflammatory state
(Lumeng et al., 2007). In parallel with the changes described
above in liver and adipose tissue, organelle stress and alterations
in Ca2+ homeostasis also play an important role in immune cell
dysfunction and inflammatory activity in metabolic disease.
For example, macrophages isolated from genetically obese
(ob/ob) mice display increased IP3R1 activity, which leads to
higher Ca2+ release from the ER to the cytosol. This process
seems to involve the regulation of IP3R1 by the oxi-reductase
protein ERO1a because silencing ERO1a or IP3R1 in macro-
phages restores ER homeostasis and reduces ER stress-
induced apoptosis (Li et al., 2009). Macrophages from ob/ob
mice and insulin-resistant IRS1-deficient mice also display
reduced levels of SERCA2b mRNA and protein expression
and, accordingly, a depleted ER Ca2+ pool. Interestingly, this
effect is linked to reduced MEK signaling because expression
of constitutively active MEK in insulin-resistant macrophages in-
duces SERCAmRNAexpression and, subsequently, restores ER
Ca2+ stores (Liang et al., 2012). These results suggest a direct
role for defective SERCA activity, ER stress, and cytoplasmic
Ca2+ signaling in the apoptosis and inflammatory phenotype of390 Cell Metabolism 22, September 1, 2015 ª2015 Elsevier Inc.macrophages. Macrophage ER stress is also an important un-
derlying factor in the pathogenesis of atherosclerosis (Hotamisli-
gil, 2010a; Tabas, 2010). In vivo monitoring has documented the
activation of the unfolded protein response in macrophages dur-
ing the progression of atherosclerosis (Thorp et al., 2011), and
macrophage apoptosis and plaque instability are linked to ER
stress induced by increased levels of circulating lipids (Dev-
ries-Seimon et al., 2005; Seimon et al., 2010). Furthermore,
administration of chemical chaperones or suppression of a lipid
binding protein to alleviate ER stress decreases lipid-induced
macrophage apoptosis in vitro and the formation of atheroscle-
rotic plaques in vivo (Erbay et al., 2009).
Alterations in Ca2+ signaling have also been tied to macro-
phage dysfunction in metabolic disease. For example, rising
cytosolic Ca2+ (either coming from outside the cell or from the
ER through IP3R-mediated Ca2+ release) has been shown to
engage the NLRP3 inflammasome pathway, and the administra-
tion of IP3R and/or RyR inhibitors reverses this effect (Horng,
2014; Murakami et al., 2012; Rossol et al., 2012). However, how
Ca2+ directly modulates NLRP3 is not well understood. It has
been suggested that Ca2+ promotes the assembly of NLRP3
components (Lee et al., 2012), whereas another possible
mechanism involves mitochondrial Ca2+ overload followed by
increasedROSproduction and PTP formation as an intermediate
step (Murakami et al., 2012). In addition, SOCE plays an impor-
tant role in inflammatory function because it is linked to the pro-
ductionof reactive oxygen species and is necessary for phagocy-
tosis by macrophages and neutrophils (Kang et al., 2012; Zhang
et al., 2014a). Furthermore, the alterations inmacrophage activity
in obesity have been shown to involve CaMKK signaling. This
protein is activated in macrophages derived from obese mice,
and its deletion leads to impaired cytokine secretion and phago-
cytosis and inducesmorphological changes. Interestingly, obese
animals lacking CaMKKare protected fromhigh-fat diet-induced
glucose intolerance, indicating the relevance in an immunometa-
bolic context (Racioppi et al., 2012).
Finally, the production of cytokines and immunomodulators by
immune cells can also affect Ca2+ signaling in other metabolic
cells. This is evident in the pancreas, for example, in the context
of both type 1 and type 2 diabetes. In type 1 diabetes, cytokines
such as interleukin-1 (IL-1) and interferon (IFN) produced by im-
mune cells (T cells and macrophages) act via NF-kB activation
and nitric oxide production in b cells to suppress SERCA2b
expression and activity (Cardozo et al., 2005; Ramadan et al.,
2011). A direct consequence is a decrease in ER luminal Ca2+
and ER stress, ultimately leading to defective adaptive re-
sponses and disease (Cardozo et al., 2005; Engin et al., 2013).
In addition, chronic treatment of b cells with a combination of
cytokines upregulates the expression of voltage L-type Ca2+
channels, resulting in increased intercellular Ca2+ (Kato et al.,
1996). Taken together, these data support a model in which
Ca2+ signaling plays an important role in mediating organelle
dysfunction and metaflammation, both by modulating immune
or metabolic cell function and by altering the responses
emanating from these cells (Figure 4C).
Concluding Remarks and Perspectives
Multiple lines of evidence presented here demonstrate that
obesity leads to the dysregulation of cytosolic and organelle
Table 1. Proteins Regulating Ca2+ Homeostasis in the ER and Mitochondria
Name/Location Isoforms/Tissue Expression Function Main Regulators References
SERCA
(ER membrane)
SERCA 1a (skeletal muscle, BAT) Ca2+ uptake
from cytosol
to ER lumen
Endogenous: Sarcolipin (skeletal muscle and heart;
reversible inhibitor); Phospholambam (skeletal
muscle and heart; reversible inhibitor).
Pharmacological: Thapsigargin (inhibitor);
Cyclopiazonic acid (CPA) (reversible inhibitor);
2,5-di-tert-butylhydroquinone (BHQ) (inhibitor).
de Meis and Vianna, 1979; Prasad et al., 2004;
Toyoshima and Inesi, 2004; Wu et al., 1995;
Vandecaetsbeek et al., 2011
SERCA 1b (skeletal muscle)
SERCA 2a (skeletal muscle, heart)
SERCA 2b (ubiquitous)
SERCA 3 (non-muscle tissues)
IP3R
(ER membrane)
IP3R1 (ubiquitous, predominantly
brain)
Ca2+ release
from ER to
cytosol
Endogenous: IP3 (activator); Low Ca2+ (activator);
High Ca2+ (inhibitor); Low ATP (activator); High
ATP (inhibitor); Regulatory kinases: PKA,
PKC, AKT, PKG, CaMK.
Protein interaction: Numerous proteins
Pharmacological: Xestopongin C (inhibitor)
Choe and Ehrlich, 2006; Foskett et al., 2007
IP3R2 (ubiquitous; main isoform
in liver and WAT)
IP3R3 (Various tissues and
cultured cells)
RyaR
(ER membrane)
RyR1 (muscle, brain) Ca2+ release
from ER to
cytosol
Endogenous: Low Ca2+ (activator); High Ca2+
(inhibitor); High Mg+ (inhibitor). Regulatory
kinases: PKA,PKG, CaMK.
Pharmacological: Ruthenium Red (inhibitor)
Fill and Copello, 2002; Meissner, 1994;
Van Petegem, 2012RyR2 (muscle, brain)
RyR3 (predominantly brain)
STIM
(ER membrane)
STIM1 (ubiquitous, predominant
isoform in most tissues)
Ca2+ entry from
extracellular
space to cytosol
Endogenous: Ca2+depletion (activator); ROS
(activator); High temperature (activator);
Hypoxia (activator); Regulatory Kinases:
SGK1, AMPK.
Pharmacological: Low 2Aminoethoxydiphenyl
borate (2APB) (activator); High 2APB (inhibitor).
Carrasco and Meyer, 2011; Soboloff
et al., 2012
STIM2 (ubiquitous, predominant
isoform in brain)
Orai
(Plasma
membrane)
Orai1 (ubiquitous) Ca2+ entry from
extracellular
milieu to cytosol,
coupled with STIM
Pharmacological: lanthanides Gd3+ and La3+
(inhibitors)
Cao et al., 2015; Gwack et al., 2008;
Hogan et al., 2010Orai2 (ubiquitous)
Orai3 (ubiquitous)
Calreticulin
(ER lumen)
Calreticulin (ubiquitous) Ca2+-binding
chaperone
Michalak et al., 2009; Prins and
Michalak, 2011
Calnexin
(ER membrane)
Calnexin (ubiquitous) Chaperone Caramelo and Parodi, 2008; Prins and
Michalak, 2011
VDAC
(Mitochondrial
outer membrane)
VDAC1 (ubiquitous, predominant
isoform in most tissues)
Forms a channel through
the outer mitochondria
membrane and allows
diffusion of small hydrophilic
molecules such as Ca2+
Endogenous: Interacting proteins: Hexokinase,Bcl2;
Regulatory Kinases: PKA,PKCe; ROS (activators)
Pharmacological: Ruthenium red (inhibitor)
Colombini, 2012; Messina et al., 2012;
Shoshan-Barmatz and Ben-Hail, 2012
VDAC2 (ubiquitous)
VDAC3 (ubiquitous)
MCU
(Mitochondrial
inner membrane)
MCU (ubiquitous) Ca2+uptake into the
mitochondria
Endogenous: Interacting proteins: MICU1/MICU2/
MICUR1/EMRE Pharmacological: Ru360 (inhibitor)
Chaudhuri et al., 2013; De Stefani et al., 2011;
De Stefani and Rizzuto, 2014; Foskett
and Philipson, 2015
Na+/Ca2+ channel,
NCLX
(Mitochondrial inner
membrane)
NCLX (ubiquitous) Ca2+ efflux from the
mitochondria to the
cytosol
Endogenous: K+ (activator); Ni2+, Mg2+, Ba2+ and
La3+ (inhibitors)
Regulatory Kinases: PKC, PINK1.
Chaudhuri et al., 2013; De Stefani et al., 2011;
De Stefani and Rizzuto, 2014; Foskett and
Philipson, 2015
BAT, brown adipose tissue; WAT, white adipose tissue.
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ReviewCa2+ fluxes and disrupted equilibrium in metabolic tissues and
immune cells, which, in turn, alters organelle homeostasis,
signaling pathways, and autophagy. These changes at the
cellular and organelle level translate directly into effects on he-
patic glucose production, lipogenesis, inflammation, and other
processes that impact systemic metabolism and overall meta-
bolic health. Therefore, Ca2+ handling could be considered a crit-
ical problem in metabolic disease.
As this field advances, we see somemajor open questions that
will guide future research. Overall, these questions relate to gaps
in the understanding ofmechanisms that are dysfunctional during
metabolic disease, for example, the role of SOCE in organelle
homeostasis and metabolic regulation and how the balance be-
tween different components of Ca2+ homeostasis are impacted
at different sites and processes of metabolic homeostasis. In
this respect, it will be interesting to explore the role of Ca2+
signaling and control of organelle function in white and brown ad-
ipose tissue and, possibly, the browning of white adipose tissue
(Bartelt andHeeren, 2014).A secondarea for exploration is the im-
munometabolic abnormalities as a function of Ca2+ homeostasis
in obesity, especially in adipose tissue but also in other organs,
andhow thesealterations are related to specificmetabolic pathol-
ogies such as insulin resistance, glucose production, lipogenesis,
defective hormoneproduction and secretion, and hyperglycemia.
Third is thecompellingpossibility supportedby recent studies that
dysfunction of the ER and mitochondria and crucial aspects of
metabolism may be integrated through Ca2+ homeostasis and
fluxes regulating systemic metabolism. Details of the molecular
components that support such integration as well as other com-
ponents of Ca2+ handling by both the ER and mitochondria will
be important areas of future research. Finally, and perhaps most
critically, studies are needed to determine howwe canbest target
Ca2+ signaling and homeostasis for therapeutic applications.
Because Ca2+ signaling is a crucial component of the normal
physiological functions of every cell type, careful considerations
are necessary to design the potential therapeutic strategies, reg-
imens, and targets as well as designing the best pharmacological
or other interventional approaches to engage or attenuate these
pathways in obesity, diabetes, and, possibly, many other chronic
immunometabolic diseases.ACKNOWLEDGMENTS
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